Time to disease progression, relapse, or death after a median follow-up of 30 months among 321 patients assigned to chemotherapy with CVP or with R-CVP. See the complete figure in the article beginning on page .
Time to disease progression, relapse, or death after a median follow-up of 30 months among 321 patients assigned to chemotherapy with CVP or with R-CVP. See the complete figure in the article beginning on page .
